Targacept Inc. (NASDAQ:TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced it will report financial results for the third quarter of 2013 on Tuesday, November 5, 2013, before the U.S. financial markets open.
Help employers find you! Check out all the jobs and post your resume.
